Question 1

What is Vega Therapeutics?

Accepted Answer

Vega Therapeutics is a Entity.

Question 2

How often does Vega Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Vega Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 08, 2026.

Question 4

When was Vega Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 13, 2026.

Question 5

What is Vega Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 65 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Vega Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Vega Therapeutics?

Accepted Answer

Incyte acquires Vega Therapeutics for VGA039 (Jun 08, 2026, 6 articles).

Question 8

How did the "Incyte acquires Vega Therapeutics for VGA039" event impact Vega Therapeutics?

Accepted Answer

Vega Therapeutics, a subsidiary of Star Therapeutics, is being acquired by Incyte for up to $2 billion, bringing its lead candidate VGA039 to a larger biopharmaceutical company for further development and commercialization.

Question 9

How did the "Incyte latarcibart Phase 1/2 data" event impact Vega Therapeutics?

Accepted Answer

Vega Therapeutics was acquired by Incyte in July 2026, bringing latarcibart into Incyte's portfolio.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.